Gadolinium-primarily based distinction brokers (GBCAs) are widely Employed in magnetic resonance imaging (MRI) to reinforce the visibility of blood vessels, tumors, inflammation, and various interior constructions. Although frequently viewed as Risk-free, concerns about GBCA toxicity have emerged in the last 20 years—significantly in people with